Abstract Details
Edoardo Malfatti, MD (APHP, Inserm U955, Université Paris Est) | Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. |
No disclosure on file | |
Jean-Marc Raymackers, MD, PhD (Cabinet Médical Boudart-Raymackers) | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Matteo Garibaldi | No disclosure on file |
Bruno Eymard, MD | No disclosure on file |
Michel Fardeau, MD | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Patrizia Susanna Mar Perrone, MD (Azienda Ospedaliera - Ospedale Civile) | No disclosure on file |